Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?

References

• Rotterdam ESHRE/ASRM- Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
   Web of Science ®Google Scholar
• Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008;89:505–522.
   PubMed Web of Science ®Google Scholar
• Buyalos RP, Lee CT. Polycystic ovary syndrome: Pathophysiology and outcome with in vitro fertilization. Fertil Steril 1996;65:1–10.
   PubMed Web of Science ®Google Scholar
• Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E, Mashiach S. The treatment of patients with polycystic ovarian syndrome by in vitro fertilization and embryo transfer: A comparison of results with those of patients with tubal infertility. Hum Reprod 1990;5:816–818.
   PubMed Web of Science ®Google Scholar
• Urman B, Fluker MR, Yuen BH, Fleige-Zahradka BG, Zouves CG, Moon YS. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. Fertil Steril 1992;57:1269–1273.
   PubMed Web of Science ®Google Scholar
• Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: A meta-analysis. Reprod Biomed Online 2006;13:628–638.
   PubMed Web of Science ®Google Scholar
• Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in vitro fertilization outcome in high responder patients. Hum Reprod 1997;12:2359–2365.
   PubMed Web of Science ®Google Scholar
• Orvieto R, Meltcer S, Homburg R, Nahum R, Rabinson J, Ashkenazi J. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization? Fertil Steril 2009;91:1466–1468.
   PubMed Web of Science ®Google Scholar
• Orvieto R, Nahum R, Meltcer S, Homburg R, Rabinson J, Anteby EY, Ashkenazi J. Controlled ovarian hyperstimulation in polycystic ovary syndrome patients: The role of body mass index. RBM Online 2009;18:333–336
   Google Scholar
• Insler V, Shoham Z, Barash A, Koistinen R, Seppälä M, Hen M, Lunenfeld B, Zadik Z. Polycystic ovaries in non-obese and obese patients: Possible pathophysiological mechanism based on new interpretation of facts and findings. Hum Reprod 1993;8:379–384.
   PubMed Web of Science ®Google Scholar
• Mulders AG, Laven JS, Eijkemans MJ, Hughes EG, Fauser BC. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: A meta-analysis. Hum Reprod Update 2003;9:429–449.
   PubMed Web of Science ®Google Scholar
• Pagán YL, Srouji SS, Jimenez Y, Emerson A, Gill S, Hall JE. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: Investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 2006;91:1309–1316.
   PubMed Web of Science ®Google Scholar
• Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002;77:1170–1177.
   PubMed Web of Science ®Google Scholar
• Ashkenazi J, Farhi J, Orvieto R, Homburg R, Dekel A, Feldberg D, Ben Rafael Z. Polycystic ovary syndrome patients as oocyte donors: The effect of ovarian stimulation protocol on the implantation rate of the recipient. Fertil Steril 1995;64:564–567.
   PubMed Web of Science ®Google Scholar
• Taylor AE, McCourt B, Martin K, Anderson EJ, Adams J, Schoebfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with PCOS. J Clin Endocrinol Metab 1997;82:2248–56.
   PubMed Web of Science ®Google Scholar
• Gordon UD, Harrison RF, Fawzy M, Hennelly B, Gordon AC. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril 2001;75:324–331.
   PubMed Web of Science ®Google Scholar
• Mendoza C, Ruiz-Requena E, Ortega E, Cremades N, Martinez F, Bernabeu R, Greco E, Tesarik J. Follicular fluid markers of oocyte developmental potential. Hum Reprod 2002;17:1017–1022.
   PubMed Web of Science ®Google Scholar
• Clifford K, Rai R, Watson H, Franks S, Regan L. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 1996;312:1508–1511.
   PubMed Web of Science ®Google Scholar
• Orvieto R. Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod 2005;20:320–322.
   PubMed Web of Science ®Google Scholar